OMEPA's Legislative Triumphs: A Tale of Relationships and Persistence

Published in Government Relations on June 03, 2024

OMEPA's Legislative Triumphs: A Tale of Relationships and Persistence

Over the past few legislative sessions, Oklahoma Medical Equipment Providers Association (OMEPA) has navigated a legislative rollercoaster. Their commitment to building relationships and advocating for patients has led to significant wins. 

Over the past couple of years, the team worked to pass H.B.1712 – Patient’s Right of Choice Act. OMEPA President Larry Dalton of Advanced Care Medical Equipment and OMEPA VP Victor Clay of Complete Care Medical tell the story of H.B.1712, which will allow DMEPOS suppliers to adequately serve patients that have access to care issues in rural markets. Simply stated, if a patient does not have an “in-network” DMEPOS supplier in their area, they will be allowed to use an out-of-network supplier and still receive in-network benefits, allowing DMEPOS suppliers to adequately serve patients that have access to care issues in the rural markets. 

The group worked to pass this bill in 2023, but at the end of the session, their bill and 60+ other bills were scrapped at the end. In the off season, the group worked with lobbyist Julia Jernigan Smith of Creative Capitol Strategies. Victor reports, “Julia connected OMEPA with key players who were necessary for success of the bill, including Oklahoma Health Care Authority, the policy department, and the Governor’s office. All had no issues with the bill.”

After support was made with the Insurance Commission and the Oklahoma Health Care Authority, the group started working on building upon the relationships they had made over the years with key legislators. In discussion with legislators, the group focused on the impact and lack of access the “in-network” contracts were having on Oklahoma beneficiaries. Their champions helped identify key legislators that OMEPA needed to build relationships with to help move the legislation (H.B.1712) forward. They worked with OMEPA providers to have specific stories or examples of harm that was happening in these legislator’s home districts. Through this effort, OMEPA built trust and rapport with their legislators. It wasn’t just about them; it was also about the Oklahoma patients they currently serve. The old political adage is in play with building a strong relationship with legislative officials, “All politics is local.”

In April, H.B.1712 seemed well on its way to passage. It received unanimous support in the Oklahoma House of Representatives and only three nays in the Oklahoma Senate, but the bill was vetoed by Gov. Stitt. OMEPA’s Board and key providers worked tirelessly with our champions in the legislature to allow for a “veto override vote” on the last day prior to sine die (end of the legislative session). Much appreciation goes out to House Speaker Charles McCaul and Senator Greg McCortney.

This is the third bill OMEPA members have worked on and have been successful in passing since becoming a state association.

As Larry Dalton comments, “We’re three for three!” when speaking about the three significant DMEPOS bills that have now been passed since OMEPA’s inception:

  • 2019 - H.B.1407 Sales Tax – exempts durable medical equipment from state sales tax in Oklahoma 
  • 2022 - H.B.2649 - Oklahoma Durable Medical Equipment Licensing Act  
  • 2023-2024 - H.B.1712 Patient’s Right of Choice – allows to adequately serve patients that have access to care issues in the rural markets. 

How Do They Do It?

“OMEPA owes much of their success to the strong relationships built with supportive state legislators over the years. The OMEPA group reports receiving a standing ovation this year in passing H.B.1712 from Senate legislators while they sat in the gallery right after the bill passed the Senate. With the passage of this bill, OMEPA has provided a great roadmap for other state associations to follow and pass in their own state legislatures,” reports John Gallagher of VGM. “It’s great to see the progress your association has made! Passing three bills is indeed an impressive feat.”

Gallagher continues, “These legislative achievements demonstrate effective teamwork and commitment to improving the lives of Oklahomans. It’s essential to continue advocating for positive change and addressing critical issues.”

Relationship Building

Since the onset of OMEPA, President Larry Dalton has stressed the importance of building relationships and telling stories to the Oklahoma state legislators. OMEPA would like to thank these Oklahoma state legislators for their efforts with H.B.1712, including Representative TJ Marti and Senator Jessica Garvin who authored the bills, and Rep. Kevin Hilbert, Speaker Charles McCall, Senator Greg McCortney, and Senator Chuck Hall, who were all very helpful in getting the bill passed. 


TAGS

  1. advocacy
  2. dmepos
  3. state association
  4. vgm government

From Our Experts

HR1 Passes House, Advances to President Trump's Desk for Signature thumbnail HR1 Passes House, Advances to President Trump's Desk for Signature After extensive negotiations and partisan debate, the House has officially passed HR1, clearing the path for the bill to be signed into law by President Donald Trump. The legislation, which aims to reduce federal healthcare expenditures, contains several provisions that may impact the durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) industry. CMS files the Proposed Rule that sheds light on the next round of the Competitive Bidding Program thumbnail CMS files the Proposed Rule that sheds light on the next round of the Competitive Bidding Program On June 30, 2025, CMS filed the anticipated Proposed Rule that includes updates to the Competitive Bidding Program (CBP). Public comments are due 60 days from June 30, 2025. Below is a high-level summary of the rule. It is critical to note that, according to the Proposed Rule Fact Sheet dated June 30, 2025, CMS has stated that they have not announced the specific product categories they are bidding or the specific timeframe for the next competition. Those specifics will be forthcoming in a fu Senate Narrowly Passes HR1, Sending It Back to House for Final Approval thumbnail Senate Narrowly Passes HR1, Sending It Back to House for Final Approval President Donald Trump's sweeping legislative package, formally titled the One Big, Beautiful Bill Act, now referred to as HR1., cleared the Senate today in a dramatic 51–50 vote, with Vice President JD Vance casting the tie-breaking vote. The bill now returns to the House, where lawmakers must decide whether to adopt the Senate's revised version or negotiate further changes before it can reach the president's desk. Several Prominent Medicaid Provisions in Senate's Budget Bill Deemed in Violation of Byrd Rule thumbnail Several Prominent Medicaid Provisions in Senate's Budget Bill Deemed in Violation of Byrd Rule Senate Parliamentarian Elizabeth MacDonough advised this week that multiple Medicaid provisions in the Senate's reconciliation bill would violate Senate procedure by violating the Byrd Rule. The Byrd Rule is a Senate-specific procedural process that allows Senators to prevent or block inclusion of extraneous provisions in reconciliation bills. Other provisions are still under review. Evaluating the Value of a Payer Contract thumbnail Evaluating the Value of a Payer Contract In our last article, Key Payers Denied Your Application Citing Their Network Is Closed – Now What?, we discussed strategies for addressing payer contracting denials due to a closed network. As indicated, this process can be an extremely time-consuming exercise with no guarantees and mixed results. Below are a few things to consider as you evaluate whether a contract is worth the extra effort. Webinar: Webinar: "Navigating The New CMS Landscape: RADs, HMVs, and Supplier Survival" on June 25 at 1 p.m. CT. The Centers for Medicare & Medicaid Services (CMS) has released its final National Coverage Determination (NCD) for RADs and HMVs used in treating chronic respiratory failure due to COPD. While the rule potentially expands access to bilevel ST therapy (RADs), it also introduces complex compliance requirements, tighter usage criteria, and increased documentation burdens—without additional reimbursement. The Return of Competitive Bidding thumbnail The Return of Competitive Bidding The Centers for Medicare & Medicaid Services (CMS) appear to be laying the groundwork for another round of the Competitive Bidding Program (CBP). While full implementation will take a couple of years, an official announcement is expected this summer—potentially as early as July. Out With The Old RAC, In With The New thumbnail Out With The Old RAC, In With The New On April 28, 2025, CMS awarded Cotiviti GOV Services LLC, the new RAC Recovery Audit Contractor (RAC) Region 3, 4, and 5 contracts. RAC Region 3 includes the following Medicare Administrative Contractor (MAC) jurisdictions: JJ, JM, and JN. RAC Region 4 includes jurisdictions: JE, JF, and JL. And RAC Region 5 includes jurisdictions: JA, JB, JC, JD, as well as the HH/H MACs: J6, J15, JK, and JM.